Prevalence of potential drug-drug interactions in cancer patients treated with oral anticancer drugs
Original Research | By van Leeuwen RW, Brundel DH, Neef C et al.
Original Research | By Watanabe M, Okura H, Okamura A et al.
Original Research | By Nomura T, Kikai M, Hori Y et al.
Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events in the ODYSSEY OUTCOMES Trial
Clinical Trial | By M Szarek, HD White, PH Steg, ODYSSEY OUTCOMES Committees and Investigators.
Effect of Aspirin on All-Cause Mortality in the Healthy Elderly
Clinical Trial | By McNeil JJ, Nelson MR, ASPREE Investigator Group.
Longitudinal Change in Galectin-3 and Incident Cardiovascular Outcomes
Original Research | By A Ghorbani, V Bhambhani, RH Christenson et al.
Guideline | By 中华医学会心血管病学分会肺血管病学组, 中华心血管病杂志编辑委员会。
Original Research | By Chen JY, He PC, Tan N et al.
Original Research | By Huang X, Redfors B, Stone GW et al.
Original Research | By Siasos G, Tsigkou V, Stone PH et al.